Sana Biotechnology, Inc. (SANA) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
SANA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SANA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export SANA earnings history in CSV or JSON format
Free sign-in required to download data
Sana Biotechnology, Inc. (SANA) Earnings Overview
As of May 8, 2026, Sana Biotechnology, Inc. (SANA) reported trailing twelve-month net income of -$234M, reflecting +20.5% year-over-year growth. The company earned $-0.90 per diluted share over the past four quarters.
Looking at the long-term picture, SANA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$13M in fiscal 2018.
Sana Biotechnology, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$136M net income, -2051.1% margin), CRSP (-$569M net income, -16569.8% margin), BEAM (-$65M net income, -57.2% margin), SANA has comparable earnings metrics. Compare SANA vs FATE →
SANA Earnings vs Peers
Earnings metrics vs comparable public companies
SANA Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$267M | +5.8% | -$273M | $-1.16 | - | - |
| 2023 | -$283M | -5.1% | -$293M | $-1.46 | - | - |
| 2022 | -$269M | +24.3% | -$273M | $-1.43 | - | - |
| 2021 | -$356M | -24.8% | -$357M | $-2.14 | - | - |
| 2020 | -$285M | -118.2% | -$161M | $-1.63 | - | - |
| 2019 | -$131M | -887.2% | -$141M | $-0.70 | - | - |
| 2018 | -$13M | - | -$8M | $-0.07 | - | - |
See SANA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SANA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SANA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSANA — Frequently Asked Questions
Quick answers to the most common questions about buying SANA stock.
Is SANA growing earnings?
SANA EPS is $-0.90, with earnings growth accelerating to +20.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-234M.
What are SANA's profit margins?
Sana Biotechnology, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are SANA's earnings?
SANA earnings data spans 2018-2024. The accelerating earnings trend is +20.5% YoY. Historical data enables comparison across business cycles.